MTF breast augmentation & dual-plane subpectoral placement for wide thorax.

The authoritative transfeminine breast augmentation protocol engineered specifically for wide thoracic anatomy. Combining biplanar subpectoral muscle dissection with high base-diameter cohesive silicone matrices to eliminate upper pole step-off, lower the inframammary fold, and create a centered, natural feminine cleavage.

Dual-plane biplanarTebbetts pocket dissection shielding the upper pole under muscle while freeing lower pole skin expansion
Wide thorax matricesHigh base-diameter cohesive gel implants custom-measured to overcome wide sternal clefts
Neo-IMF anchoringSurgically lowered inframammary fold with deep fascial fixation to center the nipple apex
1 night hospital + 7 daysAcute overnight inpatient monitoring in Bangkok or Istanbul with private concierge recovery nursing
Surgical precision

Anatomical pillars of transfeminine dual-plane augmentation

Transfeminine thoracic anatomy requires a tailored reconstructive strategy. Standard subglandular or total submuscular approaches fail to accommodate wider rib cages and tighter soft tissue envelopes. Our dual-plane protocol addresses these three structural challenges.

01

Dual-plane biplanar pocket dissection

Transfeminine chests typically present minimal subcutaneous tissue (less than 2 cm pinch thickness) in the upper pole. In our dual-plane pocket (Type I–II based on the John Tebbetts technique), the superior two-thirds of the implant is protected beneath the pectoralis major muscle, completely concealing the upper implant border and eliminating rippling or step-off deformities.

  • Eliminates visible upper pole artificial rounding and edges
  • Selective release of inferior and sternal muscle insertions
  • Reduces dynamic implant animation distortion during pectoral contraction
  • Provides lasting muscular coverage over the upper cohesive gel matrix
02

Wide thorax base diameter & cohesive gel selection

Because transfeminine rib cages are inherently broader with wider inter-nipple spacing, conventional implants can leave an unnatural, hollow sternal cleft. We utilize high base-width cohesive silicone matrices (moderate-plus and high projection) tailored to 3D thoracic anthropometry, ensuring balanced breast fullness that naturally fills the chest breadth.

  • Custom base-width calculation based on sternal notch distance
  • Form-stable cohesive silicone gel preventing fold collapse
  • Cleavage convergence: reduces the anatomical intermammary gap
  • Natural slope transition harmonizing with shoulder and waist ratios
03

Inframammary fold lowering & neo-IMF anchoring

In male-to-female transitions, the native inframammary fold (IMF) is positioned higher and flatter, with the nipple positioned lower relative to the chest wall. To achieve a sensuous, natural tear-drop slope, the surgeon surgically lowers the IMF by 2 to 4 cm and anchors the new fold to the deep rib periosteal fascia, centering the nipple at the apex of projection.

  • Surgical lowering of the native fold by 20–40 mm based on implant volume
  • Internal capsulorraphy and deep fascial suture fixation
  • Optimal lower pole tissue expansion without double-bubble deformity
  • Discreet inframammary incision concealed precisely within the new fold
Clinical scope

Transfeminine surgical candidates & revision indications

Every patient dossier is evaluated by our surgical board to determine tissue elasticity, hormone therapy duration, and anatomical rib curvature prior to operating theater admission.

Primary protocol

Primary transfeminine breast augmentation

For transgender women who have undergone hormone replacement therapy (HRT) for at least 12 months, achieving Tanner stage 2 to 3 breast bud development. Our biplanar dual-plane technique creates proportional, sensate, and feminine breasts tailored to the individual's skeletal frame.

  • Recommended after 12–24 months of stable feminizing estrogen therapy
  • Pre-operative 3D volumetric simulation and rib cage anthropometry
  • Direct submammary incision (4.0–4.5 cm) placed in the designed neo-IMF
  • Full preservation of fourth intercostal nerve sensory innervation
Corrective revision

Secondary revision & pocket conversion

Specialized reconstructive rescue for patients who received prior breast surgery elsewhere resulting in high-riding implants, severe cleavage separation, visible upper pole rippling, severe animation deformity, or Baker grade III/IV capsular contracture.

  • Conversion of failed subglandular pockets into protected dual-plane spaces
  • Total anterior capsulectomy and corrective internal capsulorraphy
  • Re-centering laterally displaced implants to close the wide sternal gap
  • Correction of bottoming-out or double-bubble deformities
Clinical pathway

The breast augmentation transformation timeline

From comprehensive 3D anthropometric planning in our European consultation suite to inpatient hospital recovery and long-term tissue settling in our private recovery sanctuary.

Phase 1

3D thoracic mapping & cohesive matrix selection

Precise chest measurements including sternal notch-to-nipple distance, base diameter, pinch thickness, and rib flare. Using high-resolution 3D simulation, your surgical team calculates the optimal cohesive gel diameter and projection to ensure cleavage proximity and natural lateral curve.

Duration: Pre-operative dossier (European suite)
Phase 2

Dual-plane biplanar dissection & neo-IMF creation

Performed under general anesthesia in laminar-flow operating theaters. The surgeon accesses the chest via a discrete inframammary micro-incision, dissects the dual-plane pocket beneath the pectoralis major, releases the inferior sternal attachments, lowers the fold, inserts the cohesive implant using a Keller funnel for touchless sterility, and securely anchors the neo-IMF.

Duration: Day of surgery (90–120 min)
Phase 3

Inpatient monitoring & stabilizing compression

One night of specialized inpatient surgical care with intravenous analgesia and anti-edema therapy. Fitted with a bespoke surgical compression brassiere and superior stabilizing band to guide the implants into their lower pole pockets. Daily private concierge nursing visits continue at your recovery sanctuary hotel.

Duration: 1 night inpatient & 7 days in sanctuary
Phase 4

Drop & fluff maturation & cleavage settling

As the pectoralis major muscle relaxes over the first 6 to 12 weeks, the implants gently settle into the lowered inframammary fold ("drop and fluff" process). Cleavage softness peaks, skin elasticity adapts to the fuller volume, and final natural projection is established with scar maturation protocols.

Duration: 1 to 6 months post-operation
Comparative analysis

Dual-plane subpectoral vs. conventional placement techniques

An evidence-based comparison of surgical implant pockets specifically evaluated for transgender women with wider thoracic structures and thinner subcutaneous tissues.

Surgical parameterGold standard Dual-plane subpectoral Subglandular / SubfascialTotal submuscular
Upper pole step-off preventionComplete (thick muscular shield hides all edges)Poor (high visibility of implant borders)Good (full muscle coverage)
Lower pole skin expansionMaximum (muscle released to expand lower skin)High (unrestricted by muscle)Constrained (muscle restricts lower projection)
Wide thorax cleavage convergenceOptimized (custom base diameter + released medial muscle)Moderate (cleavage gap often remains wide)Restricted (tight muscle limits medial positioning)
Dynamic animation distortionMinimal (lower fibers detached from breast gland)None (no muscle involvement)Severe (implant jumps visibly upon muscle flexing)
Fold lowering (neo-IMF control)Precise (direct fascial anchorage and release)Risk of bottoming-out over timeDifficult (muscle pulls implant upward)
Capsular contracture incidenceLowest (< 2.1% under Tebbetts protocol)Higher (increased contact with glandular ducts)Low (< 3.0%)

Subglandular / Subfascial

Placed directly on top of the muscle under thin skin. Generally unsuitable for transfeminine chests with thin pinch tests.

  • Upper pole step-off: High risk of visible rippling and edges
  • Lower pole expansion: Good, but risk of premature sagging
  • Wide thorax adaptation: Leaves wide gap between breasts
  • Animation distortion: None
  • Capsular contracture: Higher clinical rate

Total submuscular

Placed entirely beneath the pectoralis major and serratus muscles. Tends to compress the implant upward.

  • Upper pole step-off: Well concealed by muscle
  • Lower pole expansion: Severely constrained (flattened lower pole)
  • Wide thorax adaptation: Cannot lower the fold effectively
  • Animation distortion: Severe dynamic deformity upon flexing
  • Capsular contracture: Low
Clinical inquiries

Frequently asked clinical questions

Essential surgical guidance, implant sizing recommendations, and hormone therapy criteria for transfeminine breast augmentation.

Transgender women typically have less pre-existing glandular breast tissue and thinner subcutaneous fat across the upper chest (often less than 2 cm pinch test). Placing an implant above the muscle (subglandular) frequently results in visible artificial implant outlines, wrinkling, and a tell-tale step-off transition. Conversely, placing the implant entirely under the muscle flattens the lower breast and causes severe dynamic animation distortion when flexing. Dual-plane (biplanar) placement achieves the ideal compromise: the pectoralis major muscle conceals the upper edge, while the surgically freed lower pole expands the skin, creating a natural feminine slope and softer projection.

Transfeminine skeletal anatomy features a broader sternum and wider spacing between the nipples compared to cisgender frames. If standard-sized implants are placed, they can appear isolated on the outer chest with a wide hollow gap in the middle. Our surgical team counteracts this by:

  • Selecting implants with wider base diameters custom-scaled to thoracic width.
  • Carefully releasing the medial sternal attachments of the pectoralis major without causing symmastia.
  • Utilizing moderate-plus or high profile cohesive silicone matrices that project forward and inward, creating close, natural cleavage.

World Professional Association for Transgender Health (WPATH) standards and our surgical protocols recommend at least 12 months (ideally 18 to 24 months) of stable feminizing hormone therapy (estrogen and anti-androgens/progesterone) before undergoing breast augmentation. This allows the breast ducts and surrounding soft tissue to develop naturally to Tanner stage 2 or 3, optimizing skin elasticity and creating a soft glandular cushion over the implant.

We favor the inframammary fold (submammary) incision, measuring approximately 4.0 to 4.5 cm. This route provides the surgeon with direct, unobstructed visualization for dual-plane pocket dissection, precise lower muscle release, and accurate neo-IMF anchoring. By positioning the incision directly inside the newly created lower breast crease, the scar is naturally shadowed by the breast curve and fades into a discreet fine line over 6 to 12 months with our post-op silicone scar therapy.

Patients spend 1 night under acute medical care in our Bangkok or Istanbul hospital facility, followed by 6 to 7 days in our private recovery sanctuary hotel. Light walking is encouraged from day 1. You will wear a medical-grade surgical compression bra with a superior breast band 24/7 for the first 4 to 6 weeks. Sedentary work may resume within 7 to 10 days. Vigorous workouts, heavy lifting, and chest-focused exercises can be safely re-introduced after 6 to 8 weeks following surgical clearance.

Confidential surgical dossier

Begin your anatomical breast feminization protocol

Consult with our board-certified reconstructive plastic surgeons in Bangkok, Istanbul, or via encrypted 3D virtual consultation to plan your dual-plane subpectoral transformation.